Treat to Target in Rheumatic Diseases: Rationale and Results: Volume 45-4
Volume 45-4
Published on 30. September 2019
Book
Hardback
978-0-323-67896-4 (ISBN)
Description
Guest edited by Dr. Daniel Aletaha, this issue of Rheumatic Disease Clinics will cover "Treat to Target in Rheumatic Diseases? with a focus on rationale and results. This issue is one of four selected each year by our series Consulting Editor, Dr. Michael Weisman. Articles explore diseases, including, but not limited to: History, Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthropathies, Systemic lupus erythematosus, PMR and GCA, Inflammatory Myopathies (PM/DM), Gout, and Subclinical Targets.
More details
Series
Language
English
Place of publication
Philadelphia
United States
Target group
Professional and scholarly
Product notice
sewn/stitched
Cloth over boards
Dimensions
Height: 160 mm
Width: 238 mm
Thickness: 15 mm
Weight
390 gr
ISBN-13
978-0-323-67896-4 (9780323678964)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
Daniel Aletaha
Treat to Target in Rheumatic Diseases: Rationale and Results
E-Book
10/2019
1st Edition
Elsevier
€86.99
Available for download
Person
Daniel Aletaha is a consultant rheumatologist at the Medical University of Vienna and a renowned scientist in outcomes research, clinical trials, and translational research in rheumatoid arthritis and other inflammatory rheumatic diseases. He received academic degrees from the Medical University in Vienna, Duke University in North Carolina, and Danube University Krems. Daniel has spent more than two years at the National Institutes of Health in Bethesda, Maryland. Daniel Aletaha is a highly cited author of the field of rheumatology and author of more than 200 publications. He is also associate editor of Arthritis and Rheumatology and RMD Open, and editorial board member of a number of rheumatology specialty journals.